Agomelatine (BAN rINN; trade names Valdoxan Melitor Thymanax) is a melatonergic antidepressant developed by the pharmaceutical company Servier. It is marketed for the treatment of major depressive disorder and has been reported to not produce discontinuation syndrome and have no sexual side effects compared to SSRIs SNRIs and the older tricyclic antidepressants. Agomelatine may also have positive effects on sleep.
This page contains content from the copyrighted Wikipedia article "Agomelatine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
